Abstract: Disclosed are compositions and methods for treating conditions characterized by low HDL-CE which can lead to decreased delivery of cholesteryl ester to steroidogenic tissues, reducing the organ's ability to produce steroids especially during periods of demand, stress and or systemic inflammatory response syndrome.

Abstract: Disclosed are compositions and methods for treating conditions characterized by low HDL-CE which can lead to decreased delivery of cholesteryl ester to steroidogenic tissues, reducing the organ's ability to produce steroids especially during periods of demand, stress and or systemic inflammatory response syndrome.

Abstract: An overhead conveyor track system for a wheeled carrier having at least one wheel adapted for traveling along a track and a depending load bracket. The system includes first and second elongated conveyor tracks having respective free ends. These tracks are adapted and arranged such that the same are in substantial longitudinal alignment with the free ends thereof in spaced relationship presenting a gap therebetween. The system further includes an elongated track segment that is adapted and arranged so as to be placed in the gap in a gap closed position in substantial longitudinal alignment with the tracks. The track segment normally is in the gap in its gap closed position but is removable from the gap so as to provide the system with a gap open condition. An automatic safety switch mechanism is provided.

Abstract: Single dose formulations containing a combination of a lipid regulating agent selected from gemfibrozil, clofibrate, bezafibrate, or fenofibrate and an ACAT inhibiting agent are effective pharmacological formulations for regulating blood serum lipid and cholesterol levels.